OnKure Therapeutics, Inc.

NASDAQ:OKUR

Biotechnology

Healthcare
$2.76 +0.23%

+$0.01 today

Market cap
$111.79M
Beta
0.28
P/E (TTM)
-1.0
EPS (TTM)
-$4.30
52W Low $1.91High $5.38

Volume 0.14M

Average 0.37M

Balance Sheet

Inspect the capital base behind the business.

Assets

$62.12M

FY 2025 · Annual

-45.9% YoY

Liabilities

$5.93M

FY 2025 · Annual

-46.4% YoY

Equity

$56.18M

FY 2025 · Annual

-45.9% YoY

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents124.66M11.54M29.88M110.76M59.05M
Short-term Investments23.01M0000
Net Receivables00000
Inventory00000
Other Current Assets6.06M840K001.79M
Total Current Assets153.73M13.62M33.77M113M60.84M
Property, Plant & Equipment (Net)212K2.05M1.91M1.8M1.01M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets78K329K58K109K273K
Total Non-current Assets290K2.38M1.97M1.9M1.28M
Total Assets154.02M16M35.73M114.91M62.12M
Account Payables02.52M3.42M2.97M1.43M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.2M1.46M1.66M3.17M1.25M
Total Current Liabilities6.2M5.54M7.29M10.53M5.92M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)167K0000
Other Non-current Liabilities444K64.39M129.83M012K
Total Non-current Liabilities611K64.88M130.29M549K12K
Total Liabilities6.81M70.42M137.58M11.08M5.93M
Common Stock3K1K01K1K
Retained Earnings(84.73M)(57.07M)(102.05M)(154.72M)(214.24M)
Accumulated OCI34K0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity147.21M(54.42M)(101.84M)103.83M56.18M
Total Debt0637K674K1.09M549K
Net Debt(124.66M)(10.91M)(29.2M)(109.68M)(58.5M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$192.1M
Other Current$5.4M
Total Current Assets$197.5M
PP&E (Net)$807.0K
Other Non-current$405.0K
Total Non-current Assets$1.2M
Total Assets$198.7M

Analysis

Selected assets total $198.7M for Latest. The largest visible component is Cash & Equivalents at $192.1M, about 96.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 4, 2026
10-QQuarterly reportNov 4, 2026
SC 13GSC 13G filingOct 7, 2026
4Statement of changes in beneficial ownershipSep 23, 2026
4Statement of changes in beneficial ownershipSep 23, 2026

How much cash does OKUR have?

OnKure Therapeutics, Inc. (OKUR) reported $59.05M in cash and equivalents in fiscal 2025.

How much debt does OKUR carry?

OnKure Therapeutics, Inc. (OKUR) reported $549,000.00 of total debt, with net debt of -$58.50M.